Glycolitic enzymes are targets of oxidation in aged human frontal cortex and oxidative damage of these proteins is increased in progressive supranuclear palsy.
Progressive supranuclear palsy (PSP) is a neurodegenerative disorder pathologically characterized by neuronal loss and gliosis mainly in specific subcortical nuclei, but also in the cerebral cortex. In addition to neuron loss, hyperphosphorylated tau deposition is found in neurons, astrocytes and coiled bodies. Limited studies have shown that certain oxidative products are increased in the PSP brain. The present study examines oxidative damage in the frontal cortex in 7 PSP compared with 8 age-matched controls. Western blotting of the frontal cortex showed increased 4-hydroxy-2-nonenal (HNE)-immunoreactive bands between 40 and 50 kDa in PSP cases. Bi-dimensional gel electrophoresis and Western blotting, together with mass spectometry, were used to identify HNE-modified proteins. Oxidized phosphoglycerate kinase 1 (PGK-1) and fructose bisphosphate aldolase A (aldolase A) were identified in all cases and 4 of 7 PSP cases, respectively. In contrast, PGK-1 and aldolase A were oxidized in 3 of 8 controls. Immunohistochemistry revealed the localization of aldolase A in neurons and astrocytes, and PGK-1 mainly in astrocytes. These findings show that PGK-1 and aldolase A are targets of oxidation in the frontal cortex in the aged human cerebral cortex and that oxidative damage of these proteins is markedly increased in the frontal cortex in PSP.
Martínez
A
A
Institut de Neuropatologia, Servei Anatomia Patològica, IDIBELL-Hospital Universitari de Bellvitge, Universitat de Barcelona, Hospitalet de Llobregat, Barcelona, Spain.
Dalfó
E
E
Muntané
G
G
Ferrer
I
I
D000293:Adolescent; D000368:Aged; D000375:Aging / Q000502:physiology*; D015153:Blotting, Western; D001923:Brain Chemistry; D015180:Electrophoresis, Gel, Two-Dimensional; D005260:Female; D005625:Frontal Lobe / Q000378:metabolism* / Q000473:pathology; D005634:Fructose-Bisphosphate Aldolase / Q000032:analysis / Q000378:metabolism; D006019:Glycolysis / Q000502:physiology*; D006801:Humans; D015227:Lipid Peroxidation / Q000502:physiology*; D008297:Male; D013058:Mass Spectrometry; D008875:Middle Aged; D009457:Neuroglia / Q000378:metabolism / Q000473:pathology; D009474:Neurons / Q000378:metabolism / Q000473:pathology; D010084:Oxidation-Reduction; D018384:Oxidative Stress / Q000502:physiology*; D010735:Phosphoglycerate Kinase / Q000032:analysis / Q000378:metabolism; D013494:Supranuclear Palsy, Progressive / Q000378:metabolism* / Q000473:pathology
D010735:Phosphoglycerate Kinase; D005634:Fructose-Bisphosphate Aldolase
Trends Neurosci. 1998 Oct;21(10):428-33
9786340
J Neurochem. 1999 Aug;73(2):881-4
10428088
Neurobiol Dis. 2005 Nov;20(2):179-86
16242626
J Neural Transm (Vienna). 2003 Jan;110(1):77-94
12541014
J Neurol. 1992 Feb;239(2):98-102
1552311
Curr Neurol Neurosci Rep. 2004 Jul;4(4):296-302
15217544
J Neuropathol Exp Neurol. 1996 Jan;55(1):97-105
8558176
Neurobiol Aging. 1998 Jan-Feb;19(1 Suppl):S85-91
9562475
J Neurochem. 2000 Feb;74(2):878-81
10646541
Mov Disord. 2005 Aug;20 Suppl 12:S21-8
16092076
J Neurosci Res. 2006 Aug 1;84(2):409-17
16634065
J Neurochem. 2002 Sep;82(6):1524-32
12354300
Brain Res Brain Res Rev. 2000 Aug;33(1):95-130
10967355
Neuroscience. 2005;132(2):313-24
15802185
Brain Res. 2002 Mar 15;930(1-2):170-81
11879807
Acta Neuropathol. 2005 Sep;110(3):261-8
15973541
Mol Pathol. 2001 Dec;54(6):427-34
11724919
Curr Opin Neurol. 2000 Aug;13(4):371-6
10970052
J Neuropathol Exp Neurol. 2000 May;59(5):393-7
10888369
Brain. 2002 May;125(Pt 5):969-75
11960887
Neurobiol Aging. 2006 Jan;27(1):42-53
16298240
Annu Rev Neurosci. 2001;24:1121-59
11520930
Brain Pathol. 1999 Oct;9(4):663-79
10517506